Data: Ipsos/Axios survey; Note: ±3.2% margin of error for the total sample; Chart: Andrew Witherspoon/Axios

Fewer than 1 in 10 Americans have a great deal of trust in the Food and Drug Administration or pharmaceutical companies to look out for their interests, in the latest installment of the Axios-Ipsos Coronavirus Index.

Why it matters: This two-headed credibility crisis — over the medicine that's supposed to keep us safe and the regulators tasked with ensuring it does — shows how difficult it may be to get Americans to converge around a vaccine when the time comes.

  • This also underscores the dangers of politicizing government agencies tasked with administering science and protecting the public.

What they're saying: "It’s going to be hard for the authorities to communicate what people should be doing and how to be doing it," said pollster Chris Jackson, senior vice president for Ipsos Public Affairs.

  • "There’s going to be a huge organizational challenge in how do we get people pulling in the same direction — because nobody’s really trusted."

Between the lines: While both have their doubters, the FDA is the more trusted of the two for now.

  • 57% of Americans have some degree of trust in the FDA, though only 8% of those categorized it as a great deal of trust while the balance said they have a fair amount of trust.
  • Another 42% said they had either not very much trust in the FDA or none at all.
  • For pharmaceutical companies, the attitudes were flipped: 42% had some trust in the industry, though only 6% said they had a great deal of trust. Meanwhile, 57% said they had not very much or none at all.
  • Hispanic respondents have the most trust in both institutions; white respondents have the least.

By the numbers: More than half of respondents age 65 or older — but only one-third of adults under 30 — say they trust pharmaceutical companies.

  • Proximity to cities is a better predictor of skepticism about the FDA or pharmaceutical companies than party ID.
  • 60% of urban respondents and 57% in suburbs, but only 49% in rural areas, express trust in the FDA. When it comes to pharmaceutical companies, only one-third of rural residents express trust, 10 percentage points lower than for suburban or urban areas.

The big picture: Week 24 of our national survey reflects overall stability in U.S. attitudes toward the pandemic even as parents and school systems weigh how to return to class.

  • 35% of respondents with children under 18 say they've sent their kids back to in-person classes, while 54% have returned their kids to class via virtual or distance learning.
  • 64% of Americans say they feel about the same risk of contracting the virus as they did in April; 15% say they feel they're at greater risk, while 20% feel they're at lower risk.
  • About 9 in 10 respondents say they're wearing a mask and keeping a 6-foot distance from others.
  • 1 in 4 Americans have now been tested for the virus.
  • 6 in 10 know someone who's tested positive, and 23% know someone who's died.

Methodology: This Axios/Ipsos Poll was conducted Sept. 11–14 by Ipsos’ KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,019 general population adults age 18 or older.

  • The margin of sampling error is ± 3.2 percentage points at the 95% confidence level.

Go deeper

22 hours ago - Health

U.S. reaches 200,000 coronavirus deaths

Expand chart
Data: The Center for Systems Science and Engineering at Johns Hopkins; Chart: Axios Visuals

The coronavirus has now killed 200,000 Americans, according to Johns Hopkins data.

The big picture: Whatever context you try to put this in, it is a catastrophe of historic proportions — and is yet another reminder of America's horrific failure to contain the virus.

17 hours ago - Health

CDC releases holiday season guidance to curb COVID-19 spread

Illustration: Annelise Capossela/Axios

The Centers for Disease Control and Prevention issued holiday-specific guidelines this week to limit COVID-19 risks posed by gatherings and celebrations prior to the fall and winter holidays.

Why it matters: With the flu season just around the corner, medical experts are worried about the likelihood of battling COVID-19 and influenza at the same time. The coronavirus has now killed 200,000 Americans, and the U.S. is averaging roughly 830 per day. Cases and deaths could worsen again as the weather gets colder and people move indoors.

Hospitals want more time to repay pandemic loans

Illustration: Aïda Amer/Axios

Hospitals are approaching the deadline to repay coronavirus relief loans from the federal government, but their finances are still suffering as the pandemic drags on, Kaiser Health News reports.

The big picture: Hospitals — especially rural hospitals that were suffering before the pandemic — are hoping Congress will grant them an extension.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!